Centric Wealth Management Maia Biotechnology, Inc. Transaction History
Centric Wealth Management
- $306 Million
- Q1 2024
A detailed history of Centric Wealth Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centric Wealth Management holds 67,198 shares of MAIA stock, worth $223,769. This represents 0.05% of its overall portfolio holdings.
Number of Shares
67,198
Previous 67,198
-0.0%
Holding current value
$223,769
Previous $78,000
88.46%
% of portfolio
0.05%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding MAIA
# of Institutions
21Shares Held
661KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA282KShares$938,0010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA53.3KShares$177,3450.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX45.7KShares$152,1810.0% of portfolio
-
Virtu Financial LLC New York, NY32.5KShares$108,1810.01% of portfolio
-
Jane Street Group, LLC New York, NY25.1KShares$83,4660.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $36.4M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...